These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17564869)

  • 1. Supervised injecting facilities: how much evidence is enough?
    Maher L; Salmon A
    Drug Alcohol Rev; 2007 Jul; 26(4):351-3. PubMed ID: 17564869
    [No Abstract]   [Full Text] [Related]  

  • 2. Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice.
    Treloar C; Fraser S
    Drug Alcohol Rev; 2007 Jul; 26(4):355-61. PubMed ID: 17564870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The place of supervised injecting facilities within harm reduction: evidence, ethics and policy.
    Fry CL; Cvetkovski S; Cameron J
    Addiction; 2006 Apr; 101(4):465-7. PubMed ID: 16548922
    [No Abstract]   [Full Text] [Related]  

  • 4. Health promotion at the Medically Supervised Injecting Centre.
    White M
    Aust Nurs J; 2012 Sep; 20(3):43. PubMed ID: 23066588
    [No Abstract]   [Full Text] [Related]  

  • 5. Injection site gets 16-month extension.
    Jones D
    CMAJ; 2006 Oct; 175(8):859. PubMed ID: 17030931
    [No Abstract]   [Full Text] [Related]  

  • 6. Science, faith and AIDS: the battle over harm reduction.
    Wynia MK
    Am J Bioeth; 2005; 5(2):3-4. PubMed ID: 16036687
    [No Abstract]   [Full Text] [Related]  

  • 7. "For God's sake, don't show this letter to the president...".
    Moss AR
    Am J Public Health; 2000 Sep; 90(9):1395-6. PubMed ID: 10983195
    [No Abstract]   [Full Text] [Related]  

  • 8. Science and health policy: can they cohabit or should they divorce?
    Collins C; Coates TJ
    Am J Public Health; 2000 Sep; 90(9):1389-90. PubMed ID: 10983192
    [No Abstract]   [Full Text] [Related]  

  • 9. Attendance at supervised injecting facilities and use of detoxification services.
    Wood E; Tyndall MW; Zhang R; Stoltz JA; Lai C; Montaner JS; Kerr T
    N Engl J Med; 2006 Jun; 354(23):2512-4. PubMed ID: 16760459
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging role of supervised injecting facilities in human immunodeficiency virus prevention.
    Milloy MJ; Wood E
    Addiction; 2009 Apr; 104(4):620-1. PubMed ID: 19335659
    [No Abstract]   [Full Text] [Related]  

  • 11. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Law MG; Batey RG
    Med J Aust; 2003 Mar; 178(5):197-8. PubMed ID: 12603178
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology and the politics of needle exchange.
    Moss AR
    Am J Public Health; 2000 Sep; 90(9):1385-7. PubMed ID: 10983190
    [No Abstract]   [Full Text] [Related]  

  • 13. Critical condition facing needle exchange programs: the politics of science.
    Sherman SG
    Subst Use Misuse; 2006; 41(6-7):827-9. PubMed ID: 16809169
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects for scaling-up supervised injection facilities in Canada: the role of evidence in legal and political decision-making.
    Hyshka E; Bubela T; Wild TC
    Addiction; 2013 Mar; 108(3):468-76. PubMed ID: 23286831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five years on: what are the community perceptions of drug-related public amenity following the establishment of the Sydney Medically Supervised Injecting Centre?
    Salmon AM; Thein HH; Kimber J; Kaldor JM; Maher L
    Int J Drug Policy; 2007 Jan; 18(1):46-53. PubMed ID: 17689343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C prevention and true harm reduction.
    Madden A; Cavalieri W
    Int J Drug Policy; 2007 Oct; 18(5):335-7. PubMed ID: 17854719
    [No Abstract]   [Full Text] [Related]  

  • 17. The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.
    Islam M; Wodak A; Conigrave KM
    Int J Drug Policy; 2008 Dec; 19(6):436-41. PubMed ID: 17766100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic perspectives on injecting drug use.
    Bloom DE; Mahal A; O'Flaherty B
    Adv Health Econ Health Serv Res; 2005; 16():371-95. PubMed ID: 17867249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 20. The implicit rules of evidence-based drug policy: a U.S. perspective.
    MacCoun R; Reuter P
    Int J Drug Policy; 2008 Jun; 19(3):231-2; discussion 233-4. PubMed ID: 18424113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.